Abstract:Multiresponsive nanoprobes are highly desirable for low background and highly sensitive imaging in biomedical applications. Herein, we design a glutathione (GSH)/pH dual-responsive nanoprobe capable of both fluorescence imaging in cells and 19F magnetic resonance imaging (19F MRI) in deep tissue, by encapsulating manganese oleate (Mn(OA)2) on the surface of fluorinated fluorescent quantum dots (F-ZnS:Mn2+). In this approach, Mn(OA)2 serves as an efficient quencher of both fluorescence and 19F MRI signal. Both the fluorescence and 19F MRI signal can be turned on by introducing glutathione (GSH) that breaks up the Mn–O bonds within Mn(OA)2 under weak acidity conditions (e.g., pH 6.0). The imaging results in cells and mice suggest that this novel strategy can offer a promising nanoprobe for turn-on fluorescence/19F MRI dual-modal tumor imaging.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c01786?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c01786</a>.XRD pattern of ZnS:Mn2+ QDs (Figure S1); HRTEM images of ZnS:Mn2+-F-Mn(OA)2@PSIOAm before and after reaction with GSH (Figure S2); FT-IR spectra of ZnS:Mn2+ QDs (the ligand is oleic acid), Mn(OA)2, PFCE, PSIOAm, and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S3); UV–Vis absorption spectrum of Mn(OA)2 and fluorescence spectra of ZnS:Mn2+@PSIOAm and ZnS:Mn2+-Mn(OA)2@PSIOAm (Figure S4); UV–Vis absorption of ZnS:Mn2+OAm and ZnS:Mn2+-F-Mn(OA)2@PSIOAm (Figure S5); 19F NMR spectra of ZnS:Mn2+-F-Mn(OA)2@PSIOAm aqueous solution before and after reaction with GSH (10 mM) at pH 6.0 (Figure S6); UV–Vis absorption spectra and ICP-OES measurements of the Mn content in the supernatants of ZnS-Mn(OA)2@PSIOAm colloidal solution under different conditions (Figure S7); selectivity of ZnS:Mn2+-F-Mn(OA)2@PSIOAm toward GSH (Figure S8); cytotoxicity tests of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloids after incubation with HUVECs and 4T1 cell lines (Figure S9); flow cytometry analysis of MREpiC and 4T1 cells incubated with ZnS:Mn2+-F-NLR-Mn(OA)2@PSIOAm (Figure S10); stability evaluation of ZnS:Mn2+-F-Mn(OA)2@PSIOAm colloid solution (Figure S11); T1-weighted and T2-weighted 1H MR imaging of ZnS:Mn2+-F-Mn(OA)2@PSIOAm under different conditions (Figure S12); and fluorescence images of 4T1 cells cultured with ZnS:Mn2+-F-Mn(OA)2@PSIOAm nanoprobes for different time (Figure S13) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c01786/suppl_file/ac0c01786_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A rapid-response smart nanoplatform with dual T1-T2 activation for acidic microenvironment imaging

An Adaptable Nanoplatform for Integrating Anatomic and Functional Magnetic Resonance Imaging under a 3.0 T Magnetic Field

A Ph-Responsive T1-T2 Dual-Modal MRI Contrast Agent for Cancer Imaging

Dynamically Reversible Iron Oxide Nanoparticle Assemblies For Targeted Amplification Of T1-Weighted Magnetic Resonance Imaging Of Tumors

A pH-Sensitive Zwitterionic Iron Complex Probe with High Biocompatibility for Tumor-Specific MR Imaging.

An Acidic Ph/reduction Dual-Stimuli Responsive Nanoprobe for Enhanced CT Imaging of Tumours in Vivo.

A pH/GSH dual responsive nanoparticle with relaxivity amplification for magnetic resonance imaging and suppression of tumors and metastases

ES-MION-Based Dual-Modality PET/MRI Probes for Acidic Tumor Microenvironment Imaging

Tumor Acid Microenvironment-Triggered Self-Assembly of ESIONPs for T1/T2 Switchable Magnetic Resonance Imaging

Ph-Responsive Iron Manganese Silicate Nanoparticles As T1-T2* Dual-Modal Imaging Probes for Tumor Diagnosis.

Extremely Small Iron Oxide Nanoparticles with Ph-Dependent Solubility Transition As T1/T2 Switchable Contrast Agents for MRI

Redox-Triggered Aggregation of ESIONPs with T1 to T2 Switchable Contrasting Effect for Magnetic Resonance Imaging

A Tumor Microenvironment Dual Responsive Contrast Agent for Contrary Contrast-Magnetic Resonance Imaging and Specific Chemotherapy of Tumors

Gadolinium Metallofullerene-Based Activatable Contrast Agent for Tumor Signal Amplification and Monitoring of Drug Release.

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.

Acidity-Triggered "sticky Spotlight": CCK2R-Targeted TME-Sensitive NIR Fluorescent Probes for Tumor Imaging in Vivo.

Effective Ph-Activated Theranostic Platform for Synchronous Magnetic Resonance Imaging Diagnosis and Chemotherapy.

A Specific "Switch-On" Type Magnetic Resonance Nanoprobe With Distance-Dominate Property For High-Resolution Imaging Of Tumors

Time-Dependent T-1-T-2 Switchable Magnetic Resonance Imaging Realized by C(rgdyk) Modified Ultrasmall Fe3O4 Nanoprobes

Multiresponsive Nanoprobes for Turn-On Fluorescence/ 19 F MRI Dual-Modal Imaging

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging